HOPA/ONS TIL Webinar Series
HOPA and the Oncology Nursing Society (ONS) have collaborated on a series of three webinars, all focused on sharing knowledge about tumor-infiltrating lymphocyte (TIL) therapy for people with advanced melanoma and the logistics of bringing TIL therapy to patients.
The third 60-minute webinar session - "Essential Steps for Navigating the Tumor-Infiltrating Lymphocyte (TIL) Journey in Melanoma: Common Obstacles, Logistical Considerations, Multidisciplinary Approaches, and Best Practices Throughout the Journey of TIL Therapy" - will go live Thursday, December 19, 2024. There is 1.0 CE credit available for Webinar #3.
Live Learning Opportunities
Clear filter
-
Individual
Webinar #3: Essential Steps for Navigating the Tumor-Infiltrating Lymphocyte (TIL) Journey in Melanoma: Common Obstacles, Logistical Considerations, Multidisciplinary Approaches, and Best Practices Throughout the Journey of TIL Therapy
Live This panel session will explore the TIL journey from initial evaluation through hospitalization and supportive care, discussing common obstacles, logistical considerations, multidisciplinary approaches, and best practices associated with the TIL process. Learn more -
Individual
Webinar #2: Keep Working TIL We Beat Melanoma! The Operations and Science Behind TIL Therapy
Live Join us for the second of a three-part webinar discussion series, regarding FDA-approved TIL therapy for melanoma, operationalizing TIL therapy, and the science and side effects. Learn more